Mumbai, May 9 -- Revenue from operations shed 0.91% YoY to Rs 153.05 crore in Q4 FY26, compared with Rs 154.47 crore in the corresponding quarter last year.

The company posted a pre-tax loss of Rs 20.80 crore during the quarter against a profit before tax of Rs 11.72 crore in Q4 FY25.

EBITDA stood at Rs 25.33 crore in the quarter ended 31 March 2026, down 1.17% year on year (YoY). The EBITDA margin improved to 16.7% in Q4 FY26, as against 16.4% posted in Q4 FY25.

Segment-wise, domestic API revenue declined 2.56% year-on-year to Rs 86.85 crore, while API exports fell 5.42% to Rs 38.54 crore. Revenue from the formulations business rose 27.67% to Rs 27.67 crore during the quarter.

The said its novel anti-epileptic molecule, Cenobamate, i...